Clinical Trials: Standards
Commons · Question 54197 · Tabled 21 May 2025 · Department of Health and Social Care · Official record
Answered 2 Jun 2025
Question
Asked by Clive Jones
To ask the Secretary of State for Health and Social Care, what steps the MHRA is taking to improve (a) transparency and (b) predictability for companies seeking UK Market Authorisations.
Answer
Answered by Karin Smyth, 2 Jun 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has taken significant steps to improve transparency and predictability for companies seeking United Kingdom market authorisations. This includes clearer guidance, enhanced pre-submission scien...